[go: up one dir, main page]

WO1992014818A3 - Systeme d'expression d'entomopoxvirus comprenant des sequences de spheroïdine ou de thymidine-kinase - Google Patents

Systeme d'expression d'entomopoxvirus comprenant des sequences de spheroïdine ou de thymidine-kinase Download PDF

Info

Publication number
WO1992014818A3
WO1992014818A3 PCT/US1992/000855 US9200855W WO9214818A3 WO 1992014818 A3 WO1992014818 A3 WO 1992014818A3 US 9200855 W US9200855 W US 9200855W WO 9214818 A3 WO9214818 A3 WO 9214818A3
Authority
WO
WIPO (PCT)
Prior art keywords
sequences
spheroidin
thymidine
expression system
entomopoxvirus
Prior art date
Application number
PCT/US1992/000855
Other languages
English (en)
Other versions
WO1992014818A2 (fr
Inventor
Richard W Moyer
Richard L Hall
Michael E Gruidl
Original Assignee
Univ Florida
Richard W Moyer
Richard L Hall
Michael E Gruidl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida, Richard W Moyer, Richard L Hall, Michael E Gruidl filed Critical Univ Florida
Priority to MX9200697A priority Critical patent/MX9200697A/es
Priority to JP4508743A priority patent/JPH06506594A/ja
Priority to AU16634/92A priority patent/AU663709B2/en
Priority to IE051592A priority patent/IE920515A1/en
Priority to ZA921163A priority patent/ZA921163B/xx
Priority to IL100983A priority patent/IL100983A0/xx
Priority to CN92101985A priority patent/CN1065293A/zh
Priority to NZ241662A priority patent/NZ241662A/en
Publication of WO1992014818A2 publication Critical patent/WO1992014818A2/fr
Publication of WO1992014818A3 publication Critical patent/WO1992014818A3/fr
Priority to US09/370,861 priority patent/US6410221B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention se rapporte à de nouvelles séquences polynucléotidiques d'entomopoxvirus (EPV) qui ne sont pas associées à d'autres séquences virales avec lesquelles elles sont naturellement associées, à des vecteurs polynucléotidiques de recombinaison contenant ces séquences, à des virus de recombinaison contenant aussi ces séquences, et à des cellules hôtes infectées par ces virus de recombinaison, ainsi qu'à des procédés d'utilisation de ces séquences pour l'expression de protéines hétérologues à la fois dans des cellules hôtes d'insectes et dans celles des mammifères.
PCT/US1992/000855 1991-02-19 1992-02-12 Systeme d'expression d'entomopoxvirus comprenant des sequences de spheroïdine ou de thymidine-kinase WO1992014818A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MX9200697A MX9200697A (es) 1991-02-19 1992-02-12 Sistema de expresion de entomopoxvirus.
JP4508743A JPH06506594A (ja) 1991-02-19 1992-02-12 新規なエントモボックスウイルス発現系
AU16634/92A AU663709B2 (en) 1991-02-19 1992-02-12 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
IE051592A IE920515A1 (en) 1991-02-19 1992-02-18 Novel Entomopoxvirus Expression System
ZA921163A ZA921163B (en) 1991-02-19 1992-02-18 Novel entomopoxvirus expression system
IL100983A IL100983A0 (en) 1991-02-19 1992-02-18 Entomopoxvirus expression system
CN92101985A CN1065293A (zh) 1991-02-19 1992-02-19 新的昆虫痘病毒表达系统
NZ241662A NZ241662A (en) 1991-02-19 1992-02-19 Entomopoxvirus spheroidin, thymidine kinase and fragments, recombinant polynucleotides
US09/370,861 US6410221B1 (en) 1991-02-19 1999-08-09 Entomopoxvirus expression system

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65758491A 1991-02-19 1991-02-19
US657,584 1991-02-19
US82768592A 1992-01-30 1992-01-30
US827,685 1992-01-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US82768592A Continuation-In-Part 1991-02-19 1992-01-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US07/991,867 Continuation-In-Part US5476781A (en) 1991-02-19 1992-12-07 Entomopoxvirus spheroidin gene sequences

Publications (2)

Publication Number Publication Date
WO1992014818A2 WO1992014818A2 (fr) 1992-09-03
WO1992014818A3 true WO1992014818A3 (fr) 1992-12-10

Family

ID=27097441

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/000855 WO1992014818A2 (fr) 1991-02-19 1992-02-12 Systeme d'expression d'entomopoxvirus comprenant des sequences de spheroïdine ou de thymidine-kinase

Country Status (12)

Country Link
EP (1) EP0573613A1 (fr)
JP (1) JPH06506594A (fr)
CN (1) CN1065293A (fr)
AU (1) AU663709B2 (fr)
CA (1) CA2103550A1 (fr)
IE (1) IE920515A1 (fr)
IL (1) IL100983A0 (fr)
MX (1) MX9200697A (fr)
NZ (1) NZ241662A (fr)
WO (1) WO1992014818A2 (fr)
YU (1) YU16292A (fr)
ZA (1) ZA921163B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476781A (en) * 1991-02-19 1995-12-19 University Of Florida Research Foundation, Inc. Entomopoxvirus spheroidin gene sequences
US6130074A (en) * 1992-06-01 2000-10-10 American Cyanamid Company Five Giralda Farms Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus
JPH08501204A (ja) * 1992-06-16 1996-02-13 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼーション 組換え昆虫ポックスウイルス
US6106825A (en) * 1997-05-07 2000-08-22 University Of Florida Entomopoxvirus-vertebrate gene delivery vector and method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0397560A2 (fr) * 1989-05-08 1990-11-14 Kai-Chung Leonard Yuen ADN de la spéroidine et vecteurs d'expression d'entomopoxvirus recombinants

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0397560A2 (fr) * 1989-05-08 1990-11-14 Kai-Chung Leonard Yuen ADN de la spéroidine et vecteurs d'expression d'entomopoxvirus recombinants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Virology, vol. 175, no. 2, April 1990, Academic Press, Inc., L. Yuen et al.: "Identification and sequencing of the spheroidin gene of choristoneura biennis entomopoxvirus", pages 427-433, see the whole article *

Also Published As

Publication number Publication date
YU16292A (sh) 1994-06-24
MX9200697A (es) 1993-03-01
IE920515A1 (en) 1992-08-26
JPH06506594A (ja) 1994-07-28
NZ241662A (en) 1995-03-28
CA2103550A1 (fr) 1992-08-20
ZA921163B (en) 1992-12-30
IL100983A0 (en) 1992-11-15
EP0573613A1 (fr) 1993-12-15
WO1992014818A2 (fr) 1992-09-03
AU1663492A (en) 1992-09-15
CN1065293A (zh) 1992-10-14
AU663709B2 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
ZA923321B (en) Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus
EP2053124A3 (fr) Systèmes d'expression du virus RSV recombinant et vaccins
MX9205131A (es) Vectores de virus recombinantes.
AU2774389A (en) Recombinant vaccinia virus mva
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
EP0347365A3 (fr) Variants du virus HIV-2
WO1998013500A3 (fr) Virus mva de recombinaison exprimant des antigenes du virus de dengue et utilisation de ces derniers dans des vaccins
WO1994013812A3 (fr) Nouveaux genes de l'entomopoxvirus, nouvelles proteines et leurs procedes d'utilisation
DK251890A (da) Polypeptid og dets anvendelse samt ekspressionssystem til dets eksprimering
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
AU2855397A (en) Recombinant poxvirus and streptococcal M protein vaccine
NO177716C (no) Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
EP0554389A4 (en) Molecular clones of hiv-1 and uses thereof
CA2077434A1 (fr) Proteines antigeniques de borrelia burgdorferi
KR930701610A (ko) 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학분야에서 이들을 사용하는 방법
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
EP0868522A4 (fr) Virus de recombinaison combine de la variole et de la peritonite infectieuse du chat, compositions le contenant et leurs procedes d'obtention et d'utilisation
DK0831899T3 (da) Rekombinant koppevirus-calicivirus-præparater og anvendelser
EP0236977A3 (fr) Vaccins contre la diarrhée bovine virale et le choléra porcin
WO1992014818A3 (fr) Systeme d'expression d'entomopoxvirus comprenant des sequences de spheroïdine ou de thymidine-kinase
BR9815496A (pt) Vacinas de ácido nucléico que codificam proteìna gde vìrus sincicial respiratório
CA2245545A1 (fr) Produit vaccinal issu du gene 63 actif contre le virus varicelle-zona
WO1995012682A3 (fr) Vecteur viral a antigenes du virus de la maladie des muqueuses (bvdv)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP KR PL US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1992908955

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2103550

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 08107755

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1992908955

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1992908955

Country of ref document: EP